By Dr Adam Jacob Bryant

Conference Abstracts

Hwang A; Kurniawan S; Zhang J; Fani-Molky P; Wong Doo N; Whelan C; King T; Bryant C; Kidson- Gerber G; Bosco A; Parmar G; Lai S; Kwok F; Ling S; Ho P; Bryant A; McCaughan G; Bryant A, 2024, 'Lenalidomide, bortezomib and dexamethasone (RVd) in patients with transplant eligible newly diagnosed multiple myeloma (TE NDMM): final analysis of the NSW Harmonisation study', in Lenalidomide, bortezomib and dexamethasone (RVd) in patients with transplant eligible newly diagnosed multiple myeloma (TE NDMM): final analysis of the NSW Harmonisation study, Brisbane, Australia, presented at BLOOD, 2024, Brisbane, Australia, 27 October 2024 - 30 October 2024

Rasheed F; Ling S; Bryant A; Toong C; Hodgkins C; Taylor M, 2024, 'The use of Mass Spectrometry in the diagnosis and monitoring of plasma cell dyscrasia', in The use of Mass Spectrometry in the diagnosis and monitoring of plasma cell dyscrasia, Brisbane, Australia, presented at BLOOD, 2024, Brisbane, Australia, 27 October 2024 - 30 October 2024

Marivel A-MJ; Roberts TL; Descallar J; Aung WPP; Cheng J; Becker TM; James A; Ma Y; Bryant A; Ling S, 2023, 'Multiple Myeloma in the Culturally and Linguistically Diverse Southwestern Sydney, Australia', in Blood, American Society of Hematology, Vol. 142, pp. 6642, http://dx.doi.org/10.1182/blood-2023-185193

Bryant C; Abadir E; Doo NW; Bryant A; McCaughan G; Yang S; Vanguru V; King T; Joshua D; Ho PJ, 2023, 'P-070 Failure to clear circulating tumor cells after one week of daratumumab, bortezomib and dexamethasone is associated with a reduced progression-free survival for myeloma patients', in Clinical Lymphoma Myeloma and Leukemia, Elsevier BV, Vol. 23, pp. S73 - S73, http://dx.doi.org/10.1016/s2152-2650(23)01688-9

Li E; Bryant C; Jones E; King T; Talaulikar D; Ng J; Bryant A; Ridha Z; Doo NW; Ling S; Ho PJ; Joshua D, 2023, 'P-289 The efficacy and safety of prednisone, cyclophosphamide, doxorubicin and carmustine (PCAB) in relapsed/refractory multiple myeloma in the era of novel therapy, including as a bridge to CAR-T therapy', in Clinical Lymphoma Myeloma & Leukemia, Elsevier, Vol. 23, pp. s196, http://dx.doi.org/10.1016/s2152-2650(23)01907-9

Plesner T; Harrison SJ; Quach H; Lee CH; Bryant A; Vangsted AJ; Estell J; Delforge M; Offner F; Twomey P; Choeurng V; Li J; Hendricks R; Sumiyoshi T; Miller K; Choi E; Schjesvold FH, 2021, 'A Phase I Study of RO7297089, a B-Cell Maturation Antigen (BCMA)-CD16a Bispecific Antibody in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)', in BLOOD, ELSEVIER, GA, Atlanta, Vol. 138, presented at 63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), GA, Atlanta, 11 December 2021 - 14 December 2021, http://dx.doi.org/10.1182/blood-2021-147418

McCaughan GJ; Tran S; Durrant S; Harrison SJ; Morton J; Horvath N; Spencer A; Kerridge IH; Er JAK; Barge L; Bryant A; Filshie RJ; Choong E; Lai HC; Tiley C; Mills AK; Butler A; Moore J; Hertzberg M; Kennedy GA; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee CH; Kalff A; Xia W; Hamad N, 2020, 'Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', in Blood, American Society of Hematology, Vol. 136, pp. 11 - 12, http://dx.doi.org/10.1182/blood-2020-138991

McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', in Blood, American Society of Hematology, Vol. 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269

Haack R; Mallik S; Sungala N; Bryant A; Ho LL; Motum P, 2019, 'COPPER DEFICIENCY: DON'T YOU FORGET ABOUT ME.', in INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, WILEY, Vol. 41, pp. 68 - 68, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487566000106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Watson A-M; Bryant A; Davison S; Ling S; Levy M, 2016, 'Treatment of Otherwise Ineligible Donors for Hepatitis B Prior to Matched Sibling Allogeneic Stem Cell Transplant', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, SPAIN, Valencia, Vol. 51, pp. S140 - S140, presented at 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, SPAIN, Valencia, 03 April 2016 - 06 April 2016

Bryant A; Kershaw G; Zebeljan D; Motum P; Das R, 2013, 'Factor VIII inhibitor and pulmonary embolism developing in a patient after meningioma resection: clinical and laboratory aspects', in JOURNAL OF THROMBOSIS AND HAEMOSTASIS, WILEY-BLACKWELL, Vol. 11, pp. 1021 - 1021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331833604400&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dalal BI; Al Mugairi A; Bryant A; Lau S; Pi S; Khare NS; Pal J; Mourad YA, 2013, 'Aberrant Expression of Myeloid Antigens Identifies a Subgroup of Standard-Risk Adult Acute Lymphoblastic Leukemia Patients with Short Survival', in Transplantation and Cellular Therapy, Elsevier, Vol. 19, pp. s223 - s224, http://dx.doi.org/10.1016/j.bbmt.2012.11.268

Bryant AJ; Pillai E; Kennedy G; Kalff A; Ritchie D; George B; Hertzberg M; Patil SS; Spencer A; Fay K; Cannell P; Berkahn L; Doocey R; Spearling R; Nivison-Smith I; Moore J, 2011, 'A Retrospective Analysis of 344 Fludarabine Melphalan RIC Allogeneic Stem Cell Transplants for Myeloid and Lymphoid Malignancies In Australia and New Zealand 1998-2008', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, Vol. 118, pp. 1772 - 1772, presented at 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, CA, San Diego, 10 December 2011 - 13 December 2011

Bryant AJ; Palma CA; Lutherborrow M; Jayaswal V; Yang YH; Ma D, 2011, 'Knockdown of MicroRNA-10a in Acute Myeloid Leukaemia Cells Bearing the Nucleophosmin1 Mutation Causes Cell Death and Reduced Clonogenicity', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, Vol. 118, pp. 599 - 600, presented at 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, CA, San Diego, 10 December 2011 - 13 December 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000299597101636&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Palma CA; Tonna E; Bryaht AJ; Jayaswal V; Agapiou D; Yang YH; Ma D; Lutherborrow M, 2011, 'MicroRNA Expression in Acute Myeloid Leukaemia and Their Effects on the Differentiation of Acute Myeloid Leukaemia Cells', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, Vol. 118, pp. 1044 - 1044, presented at 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, CA, San Diego, 10 December 2011 - 13 December 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000299597103296&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Palma CA; Tonna E; Bryant AJ; Jayaswal V; Agapiou D; Yang YH; Ma D; Lutherborrow M, 2011, 'MicroRNA Expression in Acute Myeloid Leukaemia and Their Effects on the Differentiation of Acute Myeloid Leukaemia Cells', in Blood, American Society of Hematology, Vol. 118, pp. 2430, http://dx.doi.org/10.1182/blood.v118.21.2430.2430

Bryant A; Moore J; Dodds A; Milliken S; Fay K; Ma D, 2007, 'Pneumonitis and renal toxicity with sirolimus based GVHD prophylaxis for RIC allogeneic', in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, FERRATA STORTI FOUNDATION, AUSTRIA, Vienna, Vol. 92, pp. 516 - 516, presented at 12th Congress of the European-Hematology-Association, AUSTRIA, Vienna, 07 June 2007 - 10 June 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247176901661&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page